Mitchell Capital Management CO Amgen Inc Transaction History

Mitchell Capital Management CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $3.01 Million - $3.53 Million	-14,174 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $161,170 - $178,806	690 Added 5.12%	14,174 $3.46 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $248,539 - $289,632	1,120 Added 9.06%	13,484 $3.36 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $107,108 - $127,546	495 Added 4.17%	12,364 $2.84 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $83,535 - $92,898	356 Added 3.09%	11,869 $3.02 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $14,835 - $18,205	75 Added 0.66%	11,513 $2.72 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $295,411 - $391,795	1,621 Added 16.51%	11,438 $2.32 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $29,327 - $37,696	-155 Reduced 1.55%	9,817 $2.37 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $68,773 - $82,404	395 Added 4.12%	9,972 $1.93 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $565,279 - $662,635	3,391 Added 54.82%	9,577 $1.77 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $149,941 - $169,016	-829 Reduced 11.82%	6,186 $1.18 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $158,240 - $184,717	887 Added 14.47%	7,015 $1.37 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $116,732 - $131,600	630 Added 11.46%	6,128 $1.27 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $602,263 - $676,471	3,627 Added 193.85%	5,498 $1.02 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $317,003 - $370,458	1,871 New	1,871 $319,000

3,120

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

Stay updated on Mitchell Capital Management CO with notifications on news.